Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Maria Wołyniak
Observed names:
M Wolyniak,
M. Wołyniak,
Maria R. Wołyniak,
Maria Róża Maryniak,
Maria Wolyniak
Institution:
Medical University of Lodz
Observed institutions:
Instytut Biologii Doświadczalnej im. Marcelego Nenckiego,
Medical University of Lodz,
Polish Academy of Sciences
ORCID:
0009-0003-0459-0642
Observed ORCID:
0009-0003-0459-0642
OpenAlex ID:
A5003090601
Information sharing within a social network is key to behavioral flexibility—Lessons from mice tested under seminaturalistic conditions
2025
·
Maciej Winiarski
, Anna Madecka
, et al.
·
Science Advances
·
29
Neuroinflammation is responsible for pain in endometriosis - targeting the JAK-STAT pathway and mast cell activation
2025
·
Monika Golinska
, Maria Wołyniak
, et al.
·
Frontiers in Immunology
·
24
PDF
Targeted therapy of cognitive deficits in fragile X syndrome
2022
·
A. Puścian
, M. Winiarski
, et al.
·
Molecular Psychiatry
·
14
Navigating through novelties concerning mCRC treatment—the role of immunotherapy, chemotherapy, and targeted therapy in mCRC
2024
·
Edward Zheng
, Marcin Włodarczyk
, et al.
·
Frontiers in Surgery
·
12
A Crosstalk between the Cannabinoid Receptors and Nociceptin Receptors in Colitis—Clinical Implications
2022
·
Maria Wołyniak
, Ewa Małecka-Wojciesko
, et al.
·
Journal of Clinical Medicine
·
8
PDF
Cholesterol Nanofiber Patches with Sustainable Oil Delivery Eliminate Inflammation in Atopic Skin
2024
·
Ewa A. Sroczyk
, Aleksandra Tarasiuk
, et al.
·
ACS Applied Materials & Interfaces
·
7
Modulation of CB1 and CB2 receptors and endocannabinoid activity in inflammatory bowel diseases.
2024
·
M Wolyniak
, M Wlodarczyk
, et al.
·
PubMed
·
6
The endocannabinoid system as a therapeutic target in intestinal fibrosis
2025
·
Zofia Misztal
, Alicja Kaśniewska-Kosińska
, et al.
·
Frontiers in Pharmacology
·
3
PDF
WIN55,212-2 attenuates intestinal fibrosis in a DSS-induced mouse model
2026
·
Zofia Misztal
, Maria Wołyniak
, et al.
·
Pharmacological Reports
·
1
PDF
Combined CB1 antagonist AM6545 and NOP agonist SCH221510 worsen DSS-induced colitis in mice
2025
·
Adam Fabisiak
, Maria Róża Maryniak
, et al.
·
Advances in Clinical and Experimental Medicine
·
1
PDF
Dynamic Assessment of Systemic Inflammatory Markers in Predicting Pathological Complete Response After Neoadjuvant Treatment in Triple-Negative Breast Cancer
2026
·
Grzegorz J. Stępień
, Katarzyna Boguszewska-Byczkiewicz
, et al.
·
Journal of Clinical Medicine
Liquid Biopsy-Derived microRNAs in Pancreatic Ductal Adenocarcinoma: Matrix-Specific Evidence and Translational Challenges
2026
·
Maria Wołyniak
, Edward Zheng
, et al.
·
International Journal of Molecular Sciences
PDF
4038 Spatial microenvironment remodulation by preoperative chemo- and chemoradiotherapy in non-small-cell lung cancer
2025
·
Zuzanna Nowicka
, Julia Sołek
, et al.
·
Radiotherapy and Oncology
Su1186: MICRORNAS LET-7A-5P, -24-3P, AND -21-5P AS THE POTENTIAL NOVEL PANCREATIC CANCER (PDAC) BIOMARKERS IN PANCREATIC CYST FLUID AND SERUM.
2025
·
Maria Wolyniak
, Barbara Wlodarczyk
, et al.
·
Gastroenterology
Tu1178 BIOACTIVE LIPID ENDOCANNABINOIDS LEVEL IS ELEVATED IN COLON SAMPLES FROM PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD)
2024
·
Maria Wolyniak
, Marcin Wlodarczyk
, et al.
·
Gastroenterology
Show more works
View as search
Works count:
15
Citation count:
105
H-index:
6
I10-index:
4
Year
Topic
Type